MORPHEUS-EC: A phase Ib/II open-label, randomized study of first-line tiragolumab (tira) + atezolizumab (atezo) + chemotherapy (CT) in patients (pts) with esophageal cancer (EC).

Journal

Journal of Clinical Oncology

Series/Report No.

Journal of Clinical Oncology

Journal Volume

42

Start Page

324

End Page

324

Date Issued

2024-01-20

Author(s)

Sun, Jong-Mu

Chao, Yee

Kim, Sung-Bae

Rha, Sun Young

Evans, T.R. Jeffry

Strickland, Andrew

Wainberg, Zev A.

Chau, Ian

Pelles-Avraham, Sharon

Ajani, Jaffer A.

Malhotra, Ritu

Liu, Qingyuan

Li, Sijing

Cha, Edward

Rahalkar, Swapna

Allen, Simon

URI

Type

review article